Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1-Reference-Cited by-同舟云学术

Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1

Published:2015-09 Issue:36 Volume:290 Page:21876-21889
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Amazit Larbi,Le Billan Florian,Kolkhof Peter,Lamribet Khadija,Viengchareun Say,Fay Michel R.,Khan Junaid A.,Hillisch Alexander,Lombès Marc,Rafestin-Oblin Marie-Edith,Fagart Jérôme

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference57 articles.

1. The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology;Viengchareun;Nucl. Recept. Signal,2007

2. Aldosterone and mineralocorticoid receptors: past, present, and future;Funder;Endocrinology,2010

3. Aldosterone and arterial hypertension;Tomaschitz;Nat. Rev. Endocrinol,2010

4. Renal damage in primary aldosteronism: results of the PAPY Study;Rossi;Hypertension,2006

5. Aldosterone blockade: an emerging strategy for abrogating progressive renal disease;Epstein;Am. J. Med,2006

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models;International Journal of Molecular Sciences;2024-08-22

2. Finerenone and diabetic renal disease: a narrative review;Endocrine;2024-08-14

3. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes;BMC Nephrology;2024-08-01

4. Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease;Clinical Journal of the American Society of Nephrology;2024-07-22

5. The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease;Diabetes, Obesity and Metabolism;2024-07-18